MBCI
Price:
$0.0001
Market Cap:
$7.03K
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.[Read more]
Industry
Solar
IPO Date
2007-12-05
Stock Exchange
PNK
Ticker
MBCI
According to MabCure, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.17. This represents a change of 103.14% compared to the average of 0.08 of the last 4 quarters.
The mean historical Current Ratio of MabCure, Inc. over the last ten years is 0.83. The current 0.17 Current Ratio has changed 1.96% with respect to the historical average. Over the past ten years (40 quarters), MBCI's Current Ratio was at its highest in in the June 2008 quarter at 10.53. The Current Ratio was at its lowest in in the March 2007 quarter at 0.
Average
0.83
Median
0.15
Minimum
0
Maximum
4.30
Discovering the peaks and valleys of MabCure, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Current Ratio = 4.30
Minimum Annual Increase = 0%
Minimum Annual Current Ratio = 0
Year | Current Ratio | Change |
---|---|---|
2011 | 0.17 | 41.17% |
2010 | 0.12 | -66.34% |
2009 | 0.36 | -91.67% |
2008 | 4.30 | Infinity% |
2007 | 0 | 0% |
The current Current Ratio of MabCure, Inc. (MBCI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.22
5-year avg
0.99
10-year avg
0.83
MabCure, Inc.’s Current Ratio is less than Clear Blue Technologies International Inc. (1.18), less than GCL Technology Holdings Limited (1.36), less than Solar Alliance Energy Inc. (0.46), less than SinglePoint Inc. (0.21),
Company | Current Ratio | Market cap |
---|---|---|
1.18 | $1.87M | |
1.36 | $3.70B | |
0.46 | $7.34M | |
0.21 | $9.52K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MabCure, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MabCure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is MabCure, Inc.'s Current Ratio?
How is the Current Ratio calculated for MabCure, Inc. (MBCI)?
What is the highest Current Ratio for MabCure, Inc. (MBCI)?
What is the 3-year average Current Ratio for MabCure, Inc. (MBCI)?
What is the 5-year average Current Ratio for MabCure, Inc. (MBCI)?
How does the current Current Ratio for MabCure, Inc. (MBCI) compare to its historical average?